FDA introduces ‘Elsa,’ a genAI tool to drive efficiency

The technology, which has been deployed ahead of schedule after an “aggressive timeline to scale AI agency-wide,” is meant to boost productivity for clinical protocol reviews, scientific evaluations and more.

Powered by WPeMatico